Point72 Asia (Singapore) Pte. Ltd. Xeris Biopharma Holdings, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $381 Billion
- Q1 2025
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 27,268 shares of XERS stock, worth $133,067. This represents 0.04% of its overall portfolio holdings.
Number of Shares
27,268Holding current value
$133,067% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding XERS
# of Institutions
203Shares Held
84.7MCall Options Held
132KPut Options Held
69.4K-
Black Rock Inc. New York, NY10.3MShares$50.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.11MShares$39.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.29MShares$20.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.41MShares$16.6 Million0.0% of portfolio
-
State Street Corp Boston, MA3.33MShares$16.2 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $663M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...